G1 Therapeutics to Participate in the Virtual Evercore ISI HealthCONx Conference

Rhea-AI Summary

On November 30, 2022, at 1:25 PM EST, G1 Therapeutics (GTHX) will participate in the Evercore ISI HealthCONx Conference via a virtual fireside chat featuring CEO Jack Bailey and the executive team. This event will focus on G1's commitment to developing and commercializing innovative therapies for cancer patients, including their first product, COSELA® (trilaciclib). Interested parties can access the live webcast and replay on G1's Events & Presentations page.

RESEARCH TRIANGLE PARK, N.C., Nov. 23, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that Jack Bailey, G1’s Chief Executive Officer, and other members of the executive team will participate virtually in the Evercore ISI HealthCONx Conference. The fireside chat with G1 will be held at 1:25PM EST on November 30, 2022. The webcast and replay of this event will be accessible on the Events & Presentations page of http://www.g1therapeutics.com.

About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA® (trilaciclib). G1 has a deep clinical pipeline and is executing a tumor-agnostic development plan evaluating trilaciclib in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

G1 Therapeutics^® and the G1 Therapeutics logo and COSELA^® and the COSELA logo are trademarks of G1 Therapeutics, Inc.

Contacts:
Will Roberts
Vice President, Investor Relations & Corporate Communications
919-907-1944
wroberts@g1therapeutics.com

FAQ

What time is G1 Therapeutics participating in the Evercore ISI HealthCONx Conference?

G1 Therapeutics will participate in the Evercore ISI HealthCONx Conference on November 30, 2022, at 1:25 PM EST.

Who will be speaking for G1 Therapeutics at the conference?

Jack Bailey, the CEO of G1 Therapeutics, along with other executive team members, will be speaking at the conference.

Where can I watch the G1 Therapeutics conference webcast?

The webcast of the G1 Therapeutics conference can be accessed on their Events & Presentations page at www.g1therapeutics.com.

What is G1 Therapeutics known for?

G1 Therapeutics is known for developing next-generation cancer therapies, including their commercial product, COSELA® (trilaciclib).

What is the stock symbol for G1 Therapeutics?

The stock symbol for G1 Therapeutics is GTHX.